Ikarian Capital »

Ibio shares owned by Ikarian Capital

Quarter-by-quarter ownership of Ibio (IBIO) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Ibio

Tip: Access up to 7 years of quarterly data

All positions including Ibio held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ibio by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.4M 600k 4.06

More positions owned by Ikarian Capital

Krystal Biotech Put Option (KRYS)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Alnylam Pharmaceuticals (ALNY)
Crinetics Pharmaceuticals In (CRNX)
Sarepta Therapeutics (SRPT)
Corcept Therapeutics Incorporated Put Option (CORT)
Tarsus Pharmaceuticals (TARS)
Disc Medicine (IRON)
Soleno Therapeutics (SLNO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Astrazeneca Sponsored Adr Call Option (AZN)
Bridgebio Pharma (BBIO)
Eyepoint Pharmaceuticals Com New (EYPT)
Biomea Fusion Put Option (BMEA)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Ibio

Opaleye Management
ADAR1 Capital Management
Lynx1 Capital Management
Ikarian Capital
Armistice Capital
Renaissance Technologies
Sabby Management
FNY Investment Advisers
BlackRock
Tower Research Capital
UBS Group
Bnp Paribas Arbitrage, Snc
Morgan Stanley
Citigroup
Group One Trading

View all funds holding Ibio